AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
LEVETIRACETAM in Rwanda
3 products registered with RDA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LEVANEXT 750 Tablets | RWANDA-FDA25/HM/0255/0010 | — | active | 4 Feb 2031 |
| Levetiracetam UCB Solution for Oral administration | RWANDA-FDA24/HM/1015/0008 | UCB PHARMA S.A | active | 22 Sept 2030 |
| LEVANEXT 250 Film-coated tablets, | Rwanda FDA-HMP-MA-2344 | MSN Labs Private Limited | active | 18 Sept 2030 |
LEVETIRACETAM — RDA Registration Details
RDA (Rwanda) has 3 registered products containing LEVETIRACETAM, of which 3 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track LEVETIRACETAM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.